Pulmonx Corp Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Pulmonx Corp quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2018 to Q4 2023.
  • Pulmonx Corp Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $79.4M, a 16% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $79.4M +$10.9M +16% Dec 31, 2023 10-K 2024-02-27
Q4 2022 $68.4M +$11.9M +21% Dec 31, 2022 10-K 2024-02-27
Q4 2021 $56.6M +$14.6M +34.9% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $41.9M +$13M +44.8% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $29M +$4.22M +17% Dec 31, 2019 10-K 2021-03-15
Q4 2018 $24.7M Dec 31, 2018 10-K 2021-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.